Catalyst Wire Dossier Catalyst Wire Dossier

ARQ 171

· ArQule, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ARQ 171, covering 2017-03-06 to 2017-03-06. Get the full timeline:

Most recent: Clinical Trial Update: A Study of ARQ 171 in Patients With Advanced Solid Tumors [Phase 1]

See pricing